Merck · 10 hours ago
Associate Director, Analytical Technical Solutions - Millsboro, DE
Merck is a global healthcare company committed to improving health and well-being. The Associate Director, Analytical Technical Solutions is responsible for overseeing analytical lifecycle management for biologics, leading a small team, and ensuring collaboration across various departments to enhance manufacturing workflows and analytical methods.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Lead analytical lifecycle management activities for biologics, including method development, validation, transfer, and comparability assessments
Direct chromatographic and LC-MS platforms for characterization and release testing (e.g., intact/reduced mass, peptide mapping, glycan mapping, charge variants)
Serve as subject matter expert for protein/mAb analytical control strategies, specification setting, stability program design, impurity profiling, and degradation pathway assessment
Oversee site-to-site and R&D-to-site analytical transfers and integration into drug substance and drug product manufacturing processes
Author, review, and approve analytical protocols, reports, test plans, and stability protocols; ensure compliance with GMP/USDA/FDA/ICH guidelines
Lead and support investigations (OOS/OOT), root cause analysis, CAPA, and change control; partner with QC to evaluate method performance and assay robustness
Maintain strong internal and external collaborations for assay development, validation, and lifecycle improvements
Manage primary/working reference standards and critical reagents, including qualification, distribution, and long-term stewardship
Plan and manage budgets, resources, and staffing; mentor and develop a high-performing team
Oversee instrumentation strategy, including procurement, qualification, maintenance, and vendor management for HPLC, UPLC, FPLC, LC-MS, and related platforms
Monitor and assess emerging analytical technologies; contribute to regional innovation leadership and technology introduction
Qualification
Required
Master's degree with 9+ years of experience in analytical biochemistry, pharmaceutical sciences, molecular biology, biotechnology, or related discipline, with progressive technical leadership in large-molecule analytics
OR - PhD with 6+ years of experience in analytical biochemistry, pharmaceutical sciences, molecular biology, biotechnology, or related discipline, with progressive technical leadership in large-molecule analytics
Demonstrated expertise in mAb and protein therapeutic characterization; practical, hands-on experience with LC/UPLC/FPLC/SEC and LC-MS–based methods
Proficiency across key analytical modalities: UV-Vis, SDS-PAGE, Western blot, CE-SDS, HPLC/UPLC/FPLC, HPLC-SEC, LC-MS, ELISA, activity assays; experience with cell-based assays preferred
Proven leadership managing small teams (2–5 direct reports) and delivering complex method transfers and lifecycle management in a matrixed environment
Comprehensive knowledge of GMP, USDA, FDA, ICH guidelines and bioprocess operations relevant to biologics manufacturing
Competence in statistical evaluation of analytical data and use of CDS platforms such as Empower, Chromeleon, OpenLab ChemStation, or equivalent
Experience in international, cross-functional project teams, with strong project management, communication, and stakeholder alignment skills
Preferred
Deep, hands-on expertise in biochemical analysis and characterization of monoclonal antibodies and protein therapeutics
Experience driving analytical innovation initiatives and introducing new technologies across regional or global networks
Benefits
Medical
Dental
Vision healthcare
Other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
Latest News From Euronews | Euronews RSS
2026-01-22
Company data provided by crunchbase